- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/73 - CD4
Détention brevets de la classe C07K 14/73
Brevets de cette classe: 285
Historique des publications depuis 10 ans
|
11
|
16
|
23
|
23
|
51
|
35
|
39
|
35
|
31
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4140 |
26 |
| City of Hope | 966 |
17 |
| Mcmaster University | 785 |
16 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2822 |
11 |
| Immatics Biotechnologies GmbH | 1146 |
7 |
| The Trustees of the University of Pennsylvania | 4282 |
5 |
| Memorial Sloan-Kettering Cancer Center | 1887 |
5 |
| Juno Therapeutics, Inc. | 365 |
4 |
| Shattuck Labs, Inc. | 116 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6296 |
3 |
| Board of Regents, The University of Texas System | 5689 |
3 |
| The Johns Hopkins University | 5575 |
3 |
| University of Florida Research Foundation, Inc. | 3959 |
3 |
| Children's National Medical Center | 268 |
3 |
| The Council of the Queensland Institute of Medical Research | 155 |
3 |
| eFFECTOR Therapeutics, Inc. | 68 |
3 |
| International AIDS Vaccine Initiative | 89 |
3 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 179 |
3 |
| Lentigen Technology, Inc. | 98 |
3 |
| 2seventy bio, Inc. | 81 |
3 |
| Autres propriétaires | 157 |